awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36108820-56588F13-9E01-4B48-8D09-8D6A4DEE55D5
Q36108820-56588F13-9E01-4B48-8D09-8D6A4DEE55D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36108820-56588F13-9E01-4B48-8D09-8D6A4DEE55D5
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005).
P2860
Q36108820-56588F13-9E01-4B48-8D09-8D6A4DEE55D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36108820-56588F13-9E01-4B48-8D09-8D6A4DEE55D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de56e118603d38a786d136a6e6ff60b322315a6b
P2860
HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies.